Related Experiment Video
Updated: Jun 18, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk
Giuseppe Giugliano1, Gregorio Brevetti, Simona Lanero
1Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy.
Insights
Elevated total leukocyte count (TLC) and neutrophil count (NC) predict major cardiovascular events in peripheral arterial disease (PAD). These simple blood tests improve risk prediction when combined with the ankle-brachial index (ABI).
Area of Science:
- Cardiovascular Medicine
- Hematology
- Vascular Disease Research
Background:
- Elevated leukocyte count is a known cardiovascular risk predictor in general and coronary populations.
- The prognostic significance of leukocyte count in peripheral arterial disease (PAD) remains under-investigated.
Purpose of the Study:
- To evaluate the impact of leukocyte count on major cardiovascular event incidence in PAD patients.
- To determine if leukocyte count enhances the prognostic capability of the ankle-brachial index (ABI).
Main Methods:
- Prospective assessment of myocardial infarction and stroke in 259 consecutive PAD patients.
- Utilized Receiver-Operating Characteristic (ROC) analysis and bootstrap methods for outcome prediction cut-offs.
- Employed hazard ratios (HRs) and c-statistics to evaluate risk classification accuracy.
Main Results:
- Total leukocyte count (TLC) and neutrophil count (NC) were independently associated with increased cardiovascular risk (HR=1.35 and HR=1.31, respectively).
- Patients with low ABI (< or = 0.63) and high TLC (>7.7 x10^9/L) or NC (>4.6 x10^9/L) faced a five-fold increased risk.
- Combining ABI with TLC or NC significantly improved prognostic prediction (c-statistics 0.70 and 0.69) compared to ABI alone (0.61).
Conclusions:
- Inexpensive and reliable TLC and NC tests predict major cardiovascular events in PAD patients.
- Leukocyte counts significantly add to the prognostic power of the ankle-brachial index (ABI) in PAD.
- TLC and NC represent valuable, accessible tools for risk stratification in peripheral arterial disease.
Background:
An elevated leukocyte count is widely proven to predict cardiovascular risk in healthy subjects and coronary patients, but its prognostic role in peripheral arterial disease (PAD) has received scarce attention.
Objectives:
To assess the impact of leukocyte count on the incidence of major cardiovascular events in PAD, and verify whether it adds to the prognostic power of the ankle/brachial index (ABI).
Methods:
The occurrence of myocardial infarction and stroke was prospectively assessed in 259 consecutive PAD patients. Receiver-operating characteristic analysis and the bootstrap approach were used to identify the best cut-offs to predict the outcome, and hazard ratios (HRs) and c-statistics to assess the ability to classify risk.
Results:
During a median follow-up of 30.0 months, 28 patients had an event. Adjusted Cox analyses performed on total and differential leukocyte counts, showed that only total leukocyte count (TLC) and neutrophil count (NC), considered as continuous variables, were associated with increased cardiovascular risk (HR=1.35, p<0.01 and HR=1.31, p<0.02, respectively). Patients with ABI < or = 0.63 plus TLC>7.7 x10(9)/L or NC>4.6 x 10(9)/L had a higher risk of about 5-fold vs patients with ABI>0.63 plus TLC< or =7.7 x 10(9)/L (p<0.01) or NC < or = 4.6 x 10(9)/L (p<0.01). The c-statistic for ABI was 0.61, similar to those for TLC (0.63) and NC (0.66). However, it significantly increased to 0.70 and 0.69 for the models incorporating ABI and TLC or ABI and NC, respectively (p<0.05 for both vs ABI alone).
Conclusions:
TLC and NC, which are inexpensive and reliable tests, predict major cardiovascular events in PAD, and add to the prognostic power of ABI, currently the most powerful prognostic indicator in these patients.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Pre-Procedural Guidelines for Assessing Blood Pressure
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

